Pharma: Trends in e-detailing
24.6K views | +0 today
Follow
Pharma: Trends in e-detailing
Learn what is happening in e-detailing
Curated by eMedToday
Your new post is loading...
Your new post is loading...
Rescooped by eMedToday from Pharma & Medical Devices
January 9, 2017 10:14 PM
Scoop.it!

Pharma adopts data-science culture in move toward AI

Pharma adopts data-science culture in move toward AI | Pharma: Trends in e-detailing | Scoop.it
To whom does pharma turn when facing cutting-edge research challenges such as designing algorithms to comb unstructured EHR data hunting for undiagnosed pa

Via Richard Meyer
No comment yet.
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
January 9, 2017 10:14 PM
Scoop.it!

Johnson & Johnson, Rest Devices team up to launch connected sleep coaching system for babies

Johnson & Johnson, Rest Devices team up to launch connected sleep coaching system for babies | Pharma: Trends in e-detailing | Scoop.it

Boston-based Rest Devices has announced a collaboration with Johnson & Johnson to develop a smart, personalized sleep coaching system for babies (and their parents, hovering over their crib with a smartphone). The offering, which consists of a wearable baby monitor called Mimo and a companion app called Nod, was announced during the Consumer Electronics Show in Las Vegas this week.


Via Philippe Marchal, Lionel Reichardt / le Pharmageek
No comment yet.
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
January 9, 2017 10:13 PM
Scoop.it!

Pfizer creates app for patients with depression

Pfizer creates app for patients with depression | Pharma: Trends in e-detailing | Scoop.it
Brand: Pristiq

Owner: Pfizer

Duration: September 2016, ongoing

There are more than 165,000 health apps, according to a 2015 IMS Health report. Of the th

Via Dinesh Chindarkar, Lionel Reichardt / le Pharmageek
No comment yet.
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
January 2, 2017 12:36 AM
Scoop.it!

Pharma brands marketing spends by channels and region

Pharma brands marketing spends by channels and region | Pharma: Trends in e-detailing | Scoop.it
How Pharma Brands are planning to spend across markets: Top 5 trends for research agencies, publishers and adnetworks on the growing healthcare market

Via Lionel Reichardt / le Pharmageek
No comment yet.
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
December 19, 2016 9:43 PM
Scoop.it!

Will More Pharma Marketers Copy Novartis and Use Facebook Live to Tell Patient Stories?

Will More Pharma Marketers Copy Novartis and Use Facebook Live to Tell Patient Stories? | Pharma: Trends in e-detailing | Scoop.it

Marketers are taking to Facebook Live en masse, but can live social video work as a marketing tool for pharma? Yes, experts say—and it might be easier than expected.

 

The easier-than-expected part is that pharma marketers can and should build on live content they already use. For instance, pharma companies could use Facebook Live to stream conference speeches by key opinion leaders with added interactive elements, such as a question-and-answer session after.

 

The recent Novartis Facebook Live chat with Queen Latifah about heart disease (read “Novartis, Queen Latifah, & American Heart Association Team Up on Facebook Live Broadcast”; http://sco.lt/6caCxN) is another good example of a “safe” experiment where pharma can engage with patients and caregivers through disease awareness and community building,said Dave Wieneke, digital strategy practice director at Connective DX.. Patient stories in general are a good use of Facebook Live in both the initial broadcasting and in the ability to access those authentic social stories later, said Wieneke.

 

Another bonus to Facebook Live is audience building. During any particular session, viewers can click to follow all future Live sessions from the marketer.

 

In general healthcare, Wieneke noted several hospitals including the Mayo Clinic, UNC Healthcare and Children’s Hospital of Wisconsin successfully using Facebook Live with live-streaming events such as “ask a doctor” sessions, lectures, fundraisers, and guided tours. UNC Healthcare, in fact, reported results of its Facebook Live streaming that included a 480% increase in daily interactions and a 75% increase of page likes in the first six months. One of its live chats about the Affordable Care Act has been replayed more than 2,000 times.

 

The risks, which pharma companies tend to fall back on when it comes to new forms of media, are more about being live than the use of video. Potential comments made during interactive sessions around off-label use, incorrect information, or the reporting of an adverse event, for example, are the same risks as at any live event, said Wieneke.


Via Pharma Guy, Lionel Reichardt / le Pharmageek
Pharma Guy's curator insight, December 14, 2016 2:27 PM

What about Instagram? Read “Pharma on Instagram”; http://sco.lt/4nv5LV 

Scooped by eMedToday
December 13, 2016 1:27 AM
Scoop.it!

The days of the drug rep have come to an end

The days of the drug rep have come to an end | Pharma: Trends in e-detailing | Scoop.it
Pharma should move their marketing and sales efforts to the digital space exclusively.
No comment yet.
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
November 15, 2016 12:31 AM
Scoop.it!

6 Surprising Trends Shaping the Future of Pharma - The Medical Futurist

6 Surprising Trends Shaping the Future of Pharma - The Medical Futurist | Pharma: Trends in e-detailing | Scoop.it
“We don’t want to miss the train of digital health” is a phrase I often hear from pharmaceutical companies. However, there are no trains to catch anymore. Disruptive healthcare trends are the futuristic spaceships many pharma companies don’t even see flying above them. If pharma doesn’t prepare for the coming waves of change, it won’t …

Via Lionel Reichardt / le Pharmageek
No comment yet.
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
November 15, 2016 12:29 AM
Scoop.it!

Top 10 Pharmaceutical Companies 2016

Top 10 Pharmaceutical Companies 2016 | Pharma: Trends in e-detailing | Scoop.it
The global prescription pharmaceuticals market was estimated to be USD 1,114 billion in 2015. The market is mature and highly consolidated. The top-10 pharmaceutical companies in this market had share of over 30% in 2015. These companies are large and established organizations that are primarily located in U.S. and Europe. They offer drug products for…

Via Lionel Reichardt / le Pharmageek
No comment yet.
Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
October 24, 2016 1:39 AM
Scoop.it!

Future trends in pharma marketing 2016 copie

What are the new trends in healthcare marketing Where do our customers stand What key opportunities lie ahead What challenges to expect
No comment yet.
Rescooped by eMedToday from Pharma & Medical Devices
October 20, 2016 2:47 AM
Scoop.it!

Merck Survey: 4 out of 5 doctors say mobile technology is changing the office visit

Merck Survey: 4 out of 5 doctors say mobile technology is changing the office visit | Pharma: Trends in e-detailing | Scoop.it
As the focus in healthcare continues to shift towards efficiency and value, doctors say they consider themselves well-equipped to keep up with demands thanks to digital technology and information tools, according to a new survey by Merck Manuals.

Via Richard Meyer
No comment yet.
Rescooped by eMedToday from Pharma Hub
October 2, 2016 11:29 PM
Scoop.it!

Sandoz HACk – Healthcare Access Challenge

At Sandoz we believe that the biggest changes often come from amazing, small ideas. Sometimes, the only difference between a good idea and a great idea is a little bit of support. That is where Sandoz HACk comes in – the Healthcare Access Challenge.
Via Philippe Marchal
No comment yet.
Rescooped by eMedToday from Pharma Marketing
September 20, 2016 10:09 PM
Scoop.it!

Pharma's access to docs declines as nonpersonal promotion increases

Pharma's access to docs declines as nonpersonal promotion increases | Pharma: Trends in e-detailing | Scoop.it
Sales reps are now more likely to engage with physicians through nonpersonal promotion than in-person visits with doctors at their offices, a ZS report finds.

Via COUCH Medcomms
No comment yet.
Rescooped by eMedToday from #eHealthPromotion, #SaluteSocial
September 8, 2016 10:21 PM
Scoop.it!

How Poor mHealth App Usability Limits Patient Engagement

How Poor mHealth App Usability Limits Patient Engagement | Pharma: Trends in e-detailing | Scoop.it
New research shows poor mHealth app usability, which in turn limits patient engagement and chronic disease management.

mHealth apps might not be all they’re chalked up to be, especially in the realm of patient engagement and chronic disease management.

In a data brief published by the Commonwealth Fund, researchers explain how most mHealth apps have low design quality, making them essentially unusable for many patients.

The researchers, led by Urmimala Sarkar, MD, MPH, conducted an observational analysis using 11 high-rated diabetes, depression, and caregiver apps. The team asked 26 patient and caregiver participants to complete a set of tasks intended to indicate the app usability.

Overall, these apps showed significant interface design problems. The buttons were not large enough for patients, and most apps lacked instructions for easier navigation.

The apps also lacked contextual information explaining to patients why certain data entry points were important.

Limited patient education often keeps patients from fully understanding their chronic illnesses, thus keeping them from full engagement. When the tested apps did not explain to diabetics why they may want to review a past meal, the apps kept those patients from fully understanding the implications of their disease.


Via Giuseppe Fattori
No comment yet.
Rescooped by eMedToday from Pharma & Medical Devices
January 9, 2017 10:14 PM
Scoop.it!

Prognosis for Rx in 2017: more painful drug-price hikes

Prognosis for Rx in 2017: more painful drug-price hikes | Pharma: Trends in e-detailing | Scoop.it
Drug prices will jump by 12 percent in 2017 adding to high medical costs

Via Richard Meyer
No comment yet.
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
January 9, 2017 10:13 PM
Scoop.it!

Pfizer Shuns “Next Shiny Thing” When Developing Mobile Health Apps

Pfizer Shuns “Next Shiny Thing” When Developing Mobile Health Apps | Pharma: Trends in e-detailing | Scoop.it

NYC-based pharma company Pfizer currently has 15 apps in the US iOS app store, ranging from a chapstick companion app to an app for people with kidney cancer. At the HIMSS Connected Health Summit in National Harbor, Maryland, Pfizer executives talked about two of the company's apps and their broader strategy for developing mobile health interventions.

 

"We recognize that the data shows patients expect meaningful digital solutions from us, and it is our obligation to deliver that," Judy Sewards, vice president of data and digital innovations, said. "When we think about it at Pfizer, we’re not thinking about what's the next shiny thing, or what's the next widget or what everyone else is doing, but looking through the lens of our patients as people."

 

For instance, Pfizer's app for smoking cessation, called Quitter's Circle, was developed in partnership with the American Lung Association. Dennis Hancock, Pfizer VP of global commercial solutions, said all the features of that app were driven by insights into the quitting process.

 

"It would be really easy to talk about buzzwords -- telemedicine, crowdfunding," he said. "While they’re important features to the app, they had to be driven by insights into what the smoker would find useful. I don’t think chasing features is a really good idea in the mHealth space. Let’s start with insights to know what people want and overcome those barriers using the best tools available."

 

Further Reading:

  • “Pfizer Joins the #Pharma Digital Accelerator Club: Offers $250,000 in Prize Funding for Metastatic Breast Cancer “Disruptive” Technology!”; http://sco.lt/6PtsTR
  • “Pfizer and IBM Join the Parkinson's Disease ‘Internet Of Things’ Club”; http://sco.lt/7xdDP7

Via Pharma Guy, Lionel Reichardt / le Pharmageek
JEAN PASCAL POISSONNET's curator insight, January 7, 2017 11:52 AM
Put the patient at the center of R and D regarding ways of developing mobile apps and involve health pros in the process : 2 golden rules applied by Pfizer, in order to market apps with true added value. 
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
January 2, 2017 12:37 AM
Scoop.it!

The World's Most Reputable Pharmaceutical Companies In 2016

The World's Most Reputable Pharmaceutical Companies In 2016 | Pharma: Trends in e-detailing | Scoop.it
Like in most industries, players in the pharmaceutical world get a boost when customers the world over feel that they are innovators, act responsibly and are, generally speaking, a force for good. Recently a survey was published scoring exactly how good people in developed countries all over the world feel about big pharma.

Via rob halkes, Lionel Reichardt / le Pharmageek
rob halkes's curator insight, December 27, 2016 11:20 AM

Just discovered the global pharma reputation ranking by the Reputation Institute. Based on 7 dimensions of reputation, defined by the institute, the companies were evaluated by respondents around the world. These were "Products&Services, Innovation, Workplace,Governance, Citizenship, Leadership and Performance". See the RepTrak Institute here

PatientView however has studied the global reputation of pharma companies in the perspective of patients and patient groups since 2011! See here.  Their respondents were also distinguished by those who state to be familiar with a company and  those who really worked with a company, which generates interesting data! PatientView is now preparing data such that companies can retrieve their bespoke ranking data to see how their reputation in the perspective of patients can further be improved

Pharma Guy's curator insight, January 2, 2017 10:27 AM

NOTE: One trend pharmaceutical companies should take note of is the tendency of respondents to be uninformed or neutral about what companies actually do in certain areas. According to the survey, 12% of respondents did not have knowledge or opinion about the companies’ overall performance. Meanwhile, 11% had no knowledge of companies’ citizenship activities (promoting good causes and protecting the environment) and 14% didn’t know anything about the workplaces of the firms they were asked to score.

Rescooped by eMedToday from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
December 27, 2016 9:15 PM
Scoop.it!

2017 digital health predictions from Boston Children's Hospital - Vector blog

2017 digital health predictions from Boston Children's Hospital - Vector blog | Pharma: Trends in e-detailing | Scoop.it
Boston Children's Hospital's digital health predictions: reshaping of the patient journey, more patient-centric care, more clinically impactful technology.
No comment yet.
Scooped by eMedToday
December 14, 2016 12:45 AM
Scoop.it!

Five essential ingredients for digital marketing success

Five essential ingredients for digital marketing success | Pharma: Trends in e-detailing | Scoop.it
The world of digital marketing is so vast that marketers find it difficult to prioritise.
No comment yet.
Scooped by eMedToday
December 13, 2016 1:25 AM
Scoop.it!

Indian pharma sector going digital at a fast pace

Indian pharma sector going digital at a fast pace | Pharma: Trends in e-detailing | Scoop.it
Techgig.com -
No comment yet.
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
November 15, 2016 12:29 AM
Scoop.it!

Infographic: Only 10% of Docs Prefer Info Direct from #Pharma to Make Treatment Decisions

Infographic: Only 10% of Docs Prefer Info Direct from #Pharma to Make Treatment Decisions | Pharma: Trends in e-detailing | Scoop.it

How pharma distributes information to doctors is changing as rapidly as how doctors prefer to receive and process such information.


Via Pharma Guy, Lionel Reichardt / le Pharmageek
Pharma Guy's curator insight, November 11, 2016 11:12 AM

Does this include "off-label" information? If so, I understand now why most pharma presenters at the recent FDA off-label hearing focused more on communicating off-label info to payers than to HCPs.

 

P.S. MSLs and KOLs are important sources of info for docs and these sources are controlled by pharma; i.e., not independent sources of information.

Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
November 15, 2016 12:28 AM
Scoop.it!

Which Type of Paid Digital Media is Right for My Healthcare Advertising

Which Type of Paid Digital Media is Right for My Healthcare Advertising | Pharma: Trends in e-detailing | Scoop.it

From PPC ads to social network advertising, deciding which type of paid digital advertising to use for your next healthcare marketing campaign can be a challenge.

This guide covers the three most important types of paid digital advertising to help you decide which is right for your marketing needs:

PPC (Pay-Per-Click)What PPC is

PPC ads are a type of advertising in which advertisers pay a fee onlywhen someone clicks on their ads. Search engine advertising, like Google AdWords, is one of the most popular types of PPC ads.

When to use PPC

If your practice doesn’t rank highly in Google search engine results, PPC ads can help close the gap.

Organic search engine optimization takes time. PPC ads provide immediate results. PPC ads like Google AdWords also provide a plethora of digital data about the ad’s performance and keyword success.

You can use this feedback to adjust your ad’s message, the time of day the ad is shown, and narrow down the geographic region. For example, let’s say your urgent care practice wants to reach more mothers searching for urgent care for their children.

Using feedback from the campaign you’ll be able to narrow down which keyword phrases are most popular with your target audience (e.g., “urgent care children” versus “urgent care “pediatrician”) and adjust your campaign accordingly for maximum ROI.

RetargetingWhat Retargeting is

Retargeting is a type of advertising that utilizes “cookie-based technology” to track target customers who click on one of your paid ads or visits a specific page on your website.

You place a piece of code on your website that drops an anonymous browser cookie. Later, when your visitor browses other websites, the cookie will tell your retargeting provider to show an ad for your healthcare practice.

Retargeting is highly effective since it focuses your advertising spend on potential patients who have already demonstrated an interest in your practice.

When to use Retargeting

For most websites, only 2 percent of visitors convert into customers, clients or patients;retargeting allows you to stay in touch with the other 98 percent. Retargeting is great for advertising campaigns with KPIs like new patient online appointments or sign-ups for a blood drive event.

If a potential patient or donor visits the sign-up page but fails to submit the form, you can use retargeting to continue advertising to the prospective patient in an effort to bring him or her back to your website and complete the sign-up form

Social Network AdvertisingWhat Social Network Advertising is

With Facebook’s estimated social media advertising predicted to top $11 billion in revenue by 2017, according to the Marketing Tech Blog, social network advertising is big business. That’s in part because social network advertising allows businesses, including healthcare providers, to find new potential clients, customers, and patients by using social network user’s own information to identify possible interest.

Rather than relying on keyword searches to identify user intent, social media advertising can build your brand awareness with prospective patients before they even begin to search.

When to use Social Network Advertising

While paid search (e.g., PPC ads) is great for driving visitors to your website based on search intent, what if no one ever searches for your search terms, or if the most effective search terms are too expensive for your practice to bid upon?

What if you just want to build brand awareness around your healthcare practice? In both cases, social network advertising is the best option since it allows for advanced targeting, provides reliable conversion tracking, and works equally great on mobile devices and desktops.

You can target prospective patients by interest, behavior, connections, and “lookalikes” (reaching new people who have the same profile characteristics as people who already care about your business)


Via Plus91, Rémy TESTON, Lionel Reichardt / le Pharmageek
No comment yet.
Rescooped by eMedToday from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
October 20, 2016 2:48 AM
Scoop.it!

Will eDetailing Spell the Death of Traditional In-person #Pharma Sales Details?

Will eDetailing Spell the Death of Traditional In-person #Pharma Sales Details? | Pharma: Trends in e-detailing | Scoop.it

Big pharmaceutical companies have found replacements for the army of sales representatives they've laid off in recent years: digital sales tools that seek to sell doctors on drugs without the intrusion of an office visit

 

"You can't eat the orange and throw the peel away - a man is not a piece of fruit," says Willy Loman in Act 2 of Death of a Salesman. Today, many pharma sales reps may be feeling like tossed peeled fruit.

 

eDetailing in one form or another seems to be making a comeback since the recession hit the drug industry in 2007 and 2008 (see chart on right). I'm not really sure which is the "chicken" and which is the "egg"; ie, whether an uptick in adoption of eDetailing technology lead to the recent layoff of pharma reps or if reps were laid off because of the economy and subsequently replaced by machines.

 

Despite the title of this post, reports of the death of pharma "salesmen" may be somewhat exaggerated and not all sales reps can be replaced by machines.


Via Pharma Guy, ILO's Communications, Pharmacomptoir / Corinne Thuderoz, Lionel Reichardt / le Pharmageek
No comment yet.
Rescooped by eMedToday from Pharma Hub
October 20, 2016 2:44 AM
Scoop.it!

Johnson & Johnson Innovation Aims to Develop Breakthrough Medical Device Technologies

Johnson & Johnson Innovation Aims to Develop Breakthrough Medical Device Technologies | Pharma: Trends in e-detailing | Scoop.it

Johnson & Johnson Innovation LLC (JJI) announced the creation of the Center for Device Innovation at Texas Medical Center (CDI @ TMC), a broad, new collaboration between JJI and TMC that aims to accelerate end-to-end development of breakthrough medical devices.


Via Pharma Guy, Philippe Marchal
Pharma Guy's curator insight, October 18, 2016 1:06 PM

Related article: “Johnson & Johnson Expands Its Membership in the Digital Innovation Club”; http://sco.lt/65ScEr

Rescooped by eMedToday from Pharma & Medical Devices
September 26, 2016 3:30 AM
Scoop.it!

Prescription Plan Exclusion Lists Grow at Patients’ Expense – Celgene

Prescription Plan Exclusion Lists Grow at Patients’ Expense – Celgene | Pharma: Trends in e-detailing | Scoop.it
Pharmacy benefit managers are excluding more therapies from their plans, limiting treatment options for patients. Discover why this approach is a misguided.

Via Richard Meyer
No comment yet.
Scooped by eMedToday
September 13, 2016 11:25 PM
Scoop.it!

Embracing digital transformation in the Pharma and Healthcare sectors

Embracing digital transformation in the Pharma and Healthcare sectors | Pharma: Trends in e-detailing | Scoop.it
Digital technology has increased the pace of change in consumer and patient expectations, but most pharma and healthcare organisations haven’t moved quickly in response.
No comment yet.